Here, we show the beneficial effects of chronic lithium treatment on multiple measures in an SCA1 disease model—Sca1154Q/2Q mice—that express the full-length mutant protein in the endogenous spatiotemporal pattern and reproduce most features of human SCA1. The gene discussed is ATXN1; the disease is spinocerebellar ataxia type 1.